Johnson & Johnson (JNJ) Tops Q3 EPS by 15c; Raises Outlook
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $270.22 +1.10%
Revenue Growth %: +5.6%
Financial Fact:
Interest income: -97M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +5.6%
Financial Fact:
Interest income: -97M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.66, $0.15 better than the analyst estimate of $2.51. Revenue for the quarter came in at $21.4 billion versus the consensus estimate of $21.04 billion.
GUIDANCE:
Johnson & Johnson sees FY2023 EPS of $10.07-$10.13, versus the consensus of $10.03. Sees Adjusted Operational Sales up 7.2-7.7%, versus prior of 6.2-7.2%.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Rexford Industrial closes $1.2B portfolio sale to EQT Real Estate
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
